Hydroxychloroquine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE
Condition:   Antiphospholipid Syndrome Interventions:   Drug: Telitacicept;   Drug: Rituximab;   Drug: Aspirin;   Drug: Warfarin;   Drug: Hydroxychloroquine;   Drug: Prednisone Sponsor:   Qilu Hospital of Shandong University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2022 Category: Research Source Type: clinical trials